Trifecta Capital Advisors, LLC Ark Genomic Revolution ETF (De Transaction History
Trifecta Capital Advisors, LLC
- $506 Billion
- Q4 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 465 shares of ARKG stock, worth $10,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
465
Previous 465
-0.0%
Holding current value
$10,532
Previous $11.9 Million
8.02%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
288Shares Held
23.4MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$82.2 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$78.9 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$63.2 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$63 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$37.5 Million0.02% of portfolio